Blog posts

A different view to Parkinson’s disease

By Seppo Nieminen, 3 October 2018 Some years ago I volunteered in a certain project as a patient representative. I wondered for a long time though... Read More

Patients should be involved: sharing drug development news in patient seminars

By Pekka Simula 31 August 2018 I wrote earlier about the important role of patient advocacies supporting chronically ill patients. Patient groups provide information and peer... Read More

The first scientific symposium on CDNF/MANF-family proteins

Henri Huttunen 22.5.2018 One integral part of scientific research are international conferences where scientists gather together from all over the world to report their... Read More

Modern healthcare is amazingly multidisciplinary

By Pekka Simula 5 April 2018 Finland’s national TV channel YLE covered (in Finnish) an advanced therapeutic procedure in March 2018. For the first time... Read More

Partnering in drug development

By Pekka Simula 11 February 2018 Drug development is increasingly expensive. The estimated average investment required for developing a novel drug to the market varies from... Read More

FinnGen program – unique benefit for the mankind or selling Finland by the gene?

By Pekka Simula 21 December 2017 In 2017, Finland has celebrated its first century of independence. Among the many festivities and next-century-initiatives that marked the year,... Read More

Is it safe to participate in clinical studies?

By Pekka Simula 16 November 2017 Novelty implies risks. Sending humans in space, developing autonomous cars, designing faster sailing yachts - something unexpected can happen despite the... Read More

Drug developers – for a brighter future: Work practice program at Herantis Pharma

By Suvi Laitinen 6 October 2017 9th grade schoolgirl Suvi completed her work practice program at Herantis Pharma in October 2017. Let’s hear what she... Read More

Patient-centric drug development

By Pekka Simula 17 September 2017 Patient-centricity is one of the new catch phrases of the pharmaceutical industry. The 'Big Pharma’ emphasize how patient-centric they are;... Read More

Patient groups can change the world

By Pekka Simula 5 June 2017 You contract a chronic disease, get diagnosed, end up with a life-long relationship with a physician for the best available... Read More